AVITA Medical, Inc.
RCEL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $331 | $348 | $165 | $292 |
| - Cash | $14 | $22 | $18 | $56 |
| + Debt | $46 | $42 | $1 | $2 |
| Enterprise Value | $363 | $368 | $148 | $238 |
| Revenue | $64 | $50 | $34 | $33 |
| % Growth | 28.1% | 45.7% | 4.2% | – |
| Gross Profit | $55 | $42 | $28 | $27 |
| % Margin | 85.8% | 84.5% | 82.4% | 81.5% |
| EBITDA | -$55 | -$34 | -$26 | -$24 |
| % Margin | -86.1% | -66.9% | -75.7% | -73.9% |
| Net Income | -$62 | -$35 | -$27 | -$25 |
| % Margin | -96.3% | -70.6% | -77.5% | -76.1% |
| EPS Diluted | -2.39 | -1.4 | -1.57 | -1.03 |
| % Growth | -70.7% | 10.8% | -52.4% | – |
| Operating Cash Flow | -$49 | -$38 | -$19 | -$18 |
| Capital Expenditures | -$9 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$58 | -$39 | -$20 | -$19 |